Health Insight: May 04, 2026
**The End of Cancer As We Know It? New Gene-Targeted Therapy Shows Unprecedented Efficacy in Clinical Trials** **THE MEDICAL BRIEF** **London, UK & Washington D.C., USA – May 4, 2026** – A groundbreaking new class of cancer therapy, leveraging advancements in targeted protein degradation (TPD) and personalized immunotherapy, is showing “stunning” results in early-stage clinical …